粉碎的Vibegron 75毫克片的适用性用于肠道注射
Jennifer Woo1, Carla Washington1, Dorothy Aikin1
11 Sumitomo Pharma America, Inc., Marlborough, Massachusetts.
The Senior care pharmacist
|March 26, 2025
概括
粉碎的vibegron片可以安全地通过肠道食管进行注射. 这项研究证实了持续的分娩,没有堵塞或物质不相容,为患有食障碍的患者提供了可行的选择.
科学领域:
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
- 药物运输 药物运输 药物运输
背景情况:
- 维贝格龙是一种β3-上腺体受体激动剂,用于过度活跃的膀.
- 对于患有吞困难 (吞障碍) 的患者,它可以作为整片药片或用果粉粉碎.
研究的目的:
- 为了评估粉碎的树是否适合通过肠道食管给药.
- 确保安全有效的药物输送给无法吞完整片的患者.
主要方法:
- 维贝格龙75毫克片被粉碎并悬浮在水中.
- 悬浮剂通过七个常见的肠道管进行了注射.
- 用HPLC和视觉检查评估了剂量输送,材料兼容性和管道封闭.
主要成果:
- 在所有测试的肠道管中,达到了90%以上的剂量输送.
- 没有观察到管道堵塞或材料不相容.
- 平均剂量输送超过95%,并且在所有管道中一致.
结论:
- 粉碎的vibegron片被连续地和完全通过各种肠道食管输送.
- 这种方法是安全的,没有堵塞或材料不相容的证据.
- 为患有失消症的患者提供了一条实用的服药路线.
相关概念视频
Enteral Nutrition I: Orogastric and Nasogastric Feeding
157
Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
157
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
51
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
51
Routes of Drug Administration: Enteral
3.1K
Medications can be administered through the enteral route using liquids, capsules, or tablets.
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
3.1K
Drug Delivery: Enteral Route
358
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
358
Drug Delivery: Overview
267
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
267
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
169
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
169


